CSAN(CSAN)
CSAN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $16.42B | $17.33B | $14.96B | $8.37B | $8.72B |
| Low | $15.79B | $16.36B | $14.26B | $7.98B | $8.31B |
| High | $17.05B | $18.39B | $15.71B | $8.79B | $9.16B |
| EBITDA Avg | $4.98B | $5.26B | $4.54B | $2.54B | $2.65B |
| Low | $4.79B | $4.96B | $4.32B | $2.42B | $2.52B |
| High | $5.17B | $5.58B | $4.76B | $2.67B | $2.78B |
| EBIT Avg | $3.57B | $3.77B | $3.26B | $1.82B | $1.90B |
| Low | $3.44B | $3.56B | $3.10B | $1.74B | $1.81B |
| High | $3.71B | $4.00B | $3.42B | $1.91B | $1.99B |
| Net Income Avg | $-133M | $435M | $866M | $1.21B | — |
| Low | $-141M | $408M | $813M | $1.13B | — |
| High | $-125M | $463M | $922M | $1.28B | — |
| EPS Avg | $-0.11 | $0.35 | $0.69 | $0.97 | — |
| Low | $-0.11 | $0.33 | $0.65 | $0.91 | — |
| High | $-0.10 | $0.37 | $0.74 | $1.03 | — |
| Analysts (Rev / EPS) | 2 / 1 | 4 / 1 | 1 / 1 | 2 / 1 | 2 / — |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $5.52B | $5.34B |
| Low | $5.52B | $5.34B |
| High | $5.52B | $5.34B |
| EBITDA Avg | $1.68B | $1.62B |
| Low | $1.68B | $1.62B |
| High | $1.68B | $1.62B |
| EBIT Avg | $1.20B | $1.16B |
| Low | $1.20B | $1.16B |
| High | $1.20B | $1.16B |
| Net Income Avg | $85M | $28M |
| Low | $85M | $28M |
| High | $85M | $28M |
| EPS Avg | $0.09 | $0.03 |
| Low | $0.09 | $0.03 |
| High | $0.09 | $0.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |